Medicare Advantage Cancer Treatment Denied: How to Appeal
If your Medicare Advantage plan denied cancer treatment — chemotherapy, immunotherapy, radiation, or clinical trials — learn your appeal rights and how to fight back fast.
Medicare Advantage Cancer Treatment Denied: How to Appeal
Cancer treatment denials are among the most urgent and consequential insurance disputes. When a Medicare Advantage plan denies chemotherapy, immunotherapy, radiation, surgery, or a clinical trial, delays caused by a protracted appeal process can affect health outcomes. Federal law gives Medicare beneficiaries specific rights to expedited review and a multi-level appeal process that can reverse these denials quickly.
Cancer Treatments Covered by Medicare
Original Medicare — and by extension all Medicare Advantage plans — covers a broad range of oncology services, including:
- Chemotherapy (infusion-based and oral)
- Immunotherapy and targeted therapy
- Radiation therapy (external beam, brachytherapy, stereotactic radiosurgery)
- Surgery related to cancer diagnosis and treatment
- Cancer screening (colonoscopy, mammography, lung cancer CT screening, PSA testing)
- Clinical trials: Medicare covers routine costs associated with qualifying clinical trials for cancer treatment
- Anti-nausea medications related to cancer treatment
- Supportive care (pain management, palliative care, infusion services)
- Oncology specialist visits
- Genetic testing when it meets medical necessity criteria (e.g., BRCA testing, tumor marker testing)
Why Medicare Advantage Plans Deny Cancer Treatment
Common denial reasons include:
- Medical necessity: The plan claims the specific drug, regimen, or procedure is not medically necessary for your diagnosis
- Off-label use: Chemotherapy or targeted therapy used for a condition not listed in FDA labeling (even if supported by clinical compendiums like NCCN, Micromedex, or DrugDEX)
- Step therapy (fail-first): The plan requires less expensive treatments before approving the recommended therapy
- Formulary restrictions: The drug is not on the plan's formulary or requires step therapy or PA
- Clinical trial restrictions: The plan claims the trial is not a "qualifying" trial under Medicare rules
- Biosimilar substitution: Substituting an approved drug with a biosimilar you or your doctor did not agree to
- Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained
Off-Label Drug Coverage Under Medicare
A critical protection for cancer patients: Medicare (and MA plans) must cover off-label chemotherapy when it is supported by recognized clinical compendia, including:
- National Comprehensive Cancer Network (NCCN) Compendium
- DRUGDEX (Micromedex)
- Elsevier Gold Standard's Clinical Pharmacology
- American Hospital Formulary Service Drug Information (AHFS-DI)
If your oncologist is using an approved drug for an off-label cancer indication supported by NCCN or another approved compendium, your MA plan must cover it. Document this clearly in your appeal.
Medicare's Clinical Trial Protection
Under Section 2709 of the ACA (codified in Medicare law), Medicare covers routine costs of a qualifying clinical trial — including hospital stays, lab tests, and physician visits — even if the trial itself is experimental. MA plans are also bound by this rule. If the plan is denying costs associated with a clinical trial, cite 42 U.S.C. § 300gg-8 and the corresponding CMS instructions in your appeal.
Requesting an Expedited Appeal
Because cancer treatment delays can seriously harm health, you are entitled to request an expedited (72-hour) appeal at the first two levels of the MA appeals process. Your oncologist should submit a written statement supporting expedited review — this carries significant weight.
When requesting expedited review:
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
- Explicitly state that a delay in treatment could cause serious harm to your health
- Have your oncologist submit a supporting statement
- Submit the request in writing via certified mail or the plan's online portal (with confirmation)
The Full Appeals Process
Level 1 — Redetermination by the MA Plan: Submit within 60 days of denial. Expedited: plan must respond within 72 hours. Include your oncologist's letter of medical necessity, clinical records, and references to NCCN guidelines or other compendium support.
Level 2 — QIC Reconsideration: Submit within 60 days of Level 1 result. Expedited: 72 hours.
Level 3 — ALJ Hearing: Submit within 60 days of Level 2 result. Amount in controversy must meet the minimum threshold. You may submit additional expert testimony and clinical literature.
Level 4 — Medicare Appeals Council: Submit within 60 days.
Level 5 — Federal District Court: Submit within 60 days. Higher amount-in-controversy threshold applies.
Evidence for a Cancer Treatment Appeal
- Oncologist's letter of medical necessity citing diagnosis, staging, treatment rationale, and evidence base (NCCN guidelines, published clinical trial data)
- NCCN Compendium citation for off-label use
- Your treatment history: Previous treatments tried, responses, and why the requested treatment is the next appropriate step
- Published clinical studies or randomized controlled trial data supporting the treatment
- Peer-reviewed oncology guidelines from ASCO (American Society of Clinical Oncology) or relevant disease-specific society
- Clinical trial protocol if applicable
Filing a Complaint With CMS
If your MA plan is systematically denying oncology care that Medicare covers, file a complaint with CMS at 1-800-MEDICARE. CMS has audit authority over MA plans and has imposed significant fines on plans that routinely deny appropriate cancer care.
Fight Back With ClaimBack
When cancer treatment is denied, every day matters. ClaimBack helps you build a fast, comprehensive appeal that cites the correct Medicare coverage rules, oncology guidelines, and clinical evidence — giving you the strongest possible case for a reversal.
Start your appeal with ClaimBack
Related Reading
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides